The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 24, 2020
Filed:
Mar. 01, 2017
Applicant:
Bayer Pharma Aktiengesellschaft, Berlin, DE;
Inventors:
Thomas Schwarz, Wuppertal, DE;
Ningshu Liu, Berlin, DE;
Oliver Politz, Grünheide/Mark, DE;
Michael Gerisch, Wuppertal, DE;
Dieter Lang, Velbert, DE;
Assignee:
Bayer Pharma Aktiengesellschaft, Berlin, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61P 35/00 (2006.01); A61K 31/5355 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/5355 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01);
Abstract
This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.